BioBoard
•  Australia to Lead a Global Project to Document Human Variation and Transformation Genetic Health
•  EvoGenix Nets $1.66 m Grant for Cancer Work
•  First Live Porcine Vaccine in Australia
•  PharmAust Collaborates with Bristol Pharma Australia
•  Agricultural Biotechnology International Conference in Melbourne
•  Stanford Signs Pact to Provide Online Health Information to China
•  Lonza Increases Stakes in China
•  China Invests in International Traditional Chinese Medicine Programs
•  China's Science Ministry Reforms to Prevent Misconduct
•  China Harnesses Brain Power for Life Science Industry
•  Chinese Society of Biotechnology Holds Annual Conference
•  TWAS Prizes in Biology -- China and Brazil
•  China to Reform Biotech Policies
•  Bird Flu News in Indonesia
•  Hong Kong University Vice -- Chancellor Lap-Chee Tsui Appointed as an Honor Professor of Zhejiang University
•  Australia and Korea Fishing for Synergies
•  Top Indian Health Institute Sacks its Director
•  LabVantage India Eyeing the Domestic Pharma & Healthcare Market
•  India's Panacea Biotec Signs Deal with Indonesian PT Bio Pharma
•  International Congress Held in India
•  Kyowa Hakko Kogyo to Expand its Fuji Plant and Accelerate R&D for Antibody Drugs
•  Crucell Licenses Cell Line Technology to Japanese Firm
•  Malaysia's Biotechnology Asia 2006 will Gather Global Industry Players, Researchers and Entrepreneurs
•  New Zealand Launches Technology Partnership Programs
•  CombinatoRx Receives Infectious Disease Research Grant from Singapore's EDB
•  Singapore's RIEC Allocates $1.4 billion for Three Research Programs
•  ITRI and UK's Sanger Institute Sign Research Collaboration MOU
•  Warren Buffet Pledges Most of his Fortune to Gates Foundation

Special Feature
•  A Brief History, Modes of Spread and Impact of Fowl Plague Viruses
•  Avian Influenza, Thailand
•  Call for Model Assistant Influenza Pandemic Plan at All Government Levels

Industry Watch
•  EvoGenix Offered $1.2m Grant for Cancer Drug Program
•  Starpharma Lodges IND with FDA for Clinical Trial of VivaGelTM for Genital Herpes
•  CSL Proposes $108m Merger with Zenyth
•  Australian's Narhex to Collaborate with Chinese Company
•  Cytopia Announces Major License and R&D Collaboration
•  Ranbaxy Acquires Glaxo's Generic Unit in Spain
•  Theravance Collaborates with Japan's Astellas Pharma
•  Sanofi-Aventis to Collaborate with Japan's Taiho on Oral Anticancer Agent
•  Takeda Takes Global Hematide Rights in $535m Affymax Deal
•  Japan's Bioventure Today -- Immuno-Biological Laboratories Co., Ltd.
•  Sumitomo Chemical & Devgen Extend Crop Protection Collaboration
•  The Brain-Computer Interface Develops Singapore's First Clinical Candidate for Cancer
•  Pall Magnifies Focus on Asia
•  S*BIO Develops Singapore's First Clinical Candidate for Cancer

Research Findings
•  IMCB -- Unravelling the Molecular Mysteries Behind a Rare Kidney Disease

Agriculture
•  Climate Change: The Rice Genome to the Rescue

Alternative Medicine
•  Five Zang-organs Harmonize Pitch: How the Lost Theory and Technology of Huang Di Nei Jing Can be Applied to the Modern Clinical Treatment

Commentaries & Analysis
•  Efficient Plasmid Purification Strategies Simplify Scale Up of Gene Therapy and DNA Vaccines

People
•  Professor Xu Zhihong

Conference Calendar